Showing results (201-210 of 366) with videos related to
Sort By:
Pageof 37
Cancer Research Communications|June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE StudyRahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.Cancer|May 2, 2019
Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.Breast Cancer Research and Treatment|March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisPatricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.European Urology|October 29, 2021
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate CancerDaniel J Lee, Ryan Hausler, Anh N Le, et al.Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in BRCA1/2 CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.Cancer Medicine|June 8, 2021
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselorsCara N Cacioppo, Brian L Egleston, Dominique Fetzer, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.Pageof 37